Members of the Judiciary

Honorable Leonard P. Stark
United States Judge
U.S. Court of Appeals for the Federal Circuit
(Former Chief Judge, United States District Court, District of Delaware)

Honorable Julien Zavier Neals
District Judge
United States District Court, District of New Jersey

Honorable Stanley R. Chesler
District Judge
United States District Court, District of New Jersey

Honorable Maryellen Noreika
District Judge
United States District Court, District of Delaware

Honorable Mitchell Goldberg
District Judge
United States District Court, Eastern District of Pennsylvania
(Visiting Judge, District of Delaware)

Honorable Joshua Wolson
District Judge
United States District Court
Eastern District of Pennsylvania
(Visiting Judge, District of Delaware)

Honorable Douglas E. Arpert
Magistrate Judge
United States District Court, District of New Jersey

Honorable Christopher J. Burke
Magistrate Judge
District of Delaware
Government Representatives from U.S. Patent and Trademark Office

Honorable Jacqueline Bonilla
Deputy Chief Administrative Patent Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office

Honorable Susan Mitchell
Lead Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office

Honorable Grace Obermann
Administrative Patent Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office
2023 Co-Chairs

Honorable Kathleen M. O’Malley (Ret.)
Of Counsel
Irell & Manella LLP
(Former United States Circuit Judge
U.S. Court of Appeals for the Federal Circuit)

Neema Kumar
Vice President, IP, North America
Sandoz

Serena Farquharson Torres
Executive Director, Assistant General Counsel
Bristol Myers Squibb
Join the conference that the “who’s who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice.
Since 2006, when we launched our inaugural conference, pharmaceutical patent practitioners from throughout the country and in some instances across the globe have attended this conference to confer with each other and assess the implications and imprimaturs of court cases, legislation, and industry behaviors which affect the patent endgame and the pursuit of related profits. They also come to hear from Judges — both from the federal judiciary, and U.S. P.T.O.’s PTAB —, the FTC, and the FDA.
Leaders from both brand and generic drug companies recognize that this event is the single forum which serves both sides of the industry and is second to none in offering both legal and economic “take aways” for every sphere of this costly, complex and evolving litigation. This is the only event on market which not only addresses the hot topics, but also puts them within the context of pre-suit considerations, case filings, final adjudication and every step in between. This unique dynamic exemplifies not only the importance of the content and legal theory presented, but the contending business acuities as well.
We invite you to join us at this flagship event to get caught up on legal developments and learn how your peers (and opponents) are navigating the ever-changing landscape – but don’t just take our word for it, hear from Michael Sitzman (DLA Piper), Huong T. Nguyen (Fosun Pharma USA Inc.), Evan Diamond (King & Spalding LLP), and Ryan M. Daniel (Fresenius Kabi USA, LLC) about why they value this event.
A REVIEW OF ACI’s PARAGRAPH IV DISPUTES CONFERENCES
3,700+
Attendees
560+
Speakers
110+
Sponsors

DISTINGUISHED FACULTY
The best that the bar, the bench, and the industry have to offer

MASTER LEVEL STRATEGIES
For litigators and in-house counsel

UNPARALLELED CONNECTIONS
With the “Who’s Who” of Hatch-Waxman litigators

Concerned About Traveling?
Check out our WORRY-FREE GUARANTEE
Register at the preferred early rate with our worry free cancellation guarantee.
Learn More